longbridgelongbridge
  • Platform Features
    Features
    Investment ProductsPrivate Wealth ManagementTrading ToolsMarket Data ServicesAnalysis ToolsNews ServicesFor Developers
    Account Types
    For IndividualsFor Institutions
  • Café
longbridge
© 2026 Longbridge|Terms of ServicePrivacy Policy

Vivos Therapeutics

VVOS

----
Start trading
OverviewOverviewNewsNewsPostsPostsFinancialsFinancialsForecastForecastValuationValuationShareholdersShareholdersProfileProfile
LongbridgeAI

Current ValuationThe current P/E ratio is -0.13, above the reasonable range, cheaper than 0.54% of the time in the past 5 years, and the industry ranks 34/74, the industry Median --.

-0.129xP/E
$0.16Stock price
$-1.27Earnings per share
-0.129xP/E
Stock price$0.16Earnings per share$-1.27

Historical Valuation

P/E ratioTypical rangeMedian
P/E ratio
-1.00x
Typical range
-1.78x–-0.46x

Peer P/E ratio Comparison

It displays how the company's P/E ratio compares to top companies within its industry.
07142128

The industry median valuation is currently at or below 0 and may not serve as a meaningful benchmark.

Industry P/E ratio Comparison

This shows the distribution of companies by P/E ratio range and their projected earnings per share growth for the next fiscal year.
0x40x80x120x160x200x
P/E ratio
Name/Symbol
GHUSGuardant Health
-53.09x2.92%$24.07B
HIMSUSHims & Hers Health
-45.98x209.86%$6.53B
RDNTUSRadnet
-283.24x128.00%$5.98B
WGSUSGeneDx
-28.35x359.59%$3.02B
NEOUSNeogenomics
-49.31x64.73%$2.56B
AGLUSagilon health
-6.45x93.07%$1.50B
INNVUSInnovage
-587.33x2,301.70%$1.49B
OPKUSOpko Health
-17.10x25.44%$1.25B
CSTLUSCastle Biosciences
-55.61x53.28%$1.08B
LMRIUSLumexa Imaging
-38.39x146.66%$1.06B
GMRSUSGMR Solutions
-8.95x91.45%$676.89M
FLGTUSFulgent Genetics
-7.07x42.64%$596.81M
PREUSPrenetics Global
-8.82x16.63%$414.70M
AONCUSAmerican Oncology Network
----$371.06M
BDSXUSBiodesix
-11.10x42.77%$308.09M
GAMGUSGlobal Asset Management Group, Inc.
-382.11x--$215.67M
AIRSUSAirSculpt Tech
-14.19x33.33%$166.54M
NAKAUSNakamoto
-0.39x101.83%$164.10M
CORBFUSGlobal Cord Blood Corporation
----$127.35M
PARKUSPark Dental Partners
-27.36x--$96.72M

Risk Warning

Timeframes using financial data from S&P Global. The feature provides key metrics such as price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S) ratios, and dividend yield. For reference only and does not constitute investment advice.